IBD Registry
  • COVID-19
    • Story of the COVID-19 IBD Risk Tool
  • News
  • Clinical teams
    • Data Submission
    • Registry Webtool
    • Hospital Clinical Systems
    • Consent and Patient Information
    • National Opt-Out
    • Resources for Hospitals
  • Patients
    • IBD Patient Advisory Group
  • Quality & Audit
    • IBD Clinical KPIs & Audit
    • New IBD Standards
    • Quality Accounts
  • Analysis and Research
  • Partnering
    • Studies
    • Industry Forum 2021
    • Our Industry Working Group
    • Our Industry Supporters
  • Drug Safety
Select Page

Impact of IBD therapy on SARS-CoV-2 and COVID-19

Summary

(lay summary here)

 

About us

About us
Case studies
News
Work for us

Contact us

020 3393 3969
support@ibdregistry.org.uk

Information

Privacy Statement
COPI Information
Cookie Policy
Transparency information

Follow us

Join our mailing list
Follow @IBDRegistry

IBD Registry Ltd is a not-for-profit company limited by guarantee - Company Number 11197749.

© IBD Registry Ltd. All rights reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. More Info